BACKGROUND/AIMS: The association between chronic kidney disease (CKD) awareness and healthy behaviors is unknown. We examined whether CKD self-recognition is associated with healthy behaviors and achieving risk-reduction targets known to decrease risk of cardiovascular morbidity and CKD progression. METHODS: CKD awareness, defined as a 'yes' response to 'Has a doctor or other health professional ever told you that you had kidney disease?', was examined among adults with CKD (eGFR <60 ml/min/1.73 m(2)) who participated in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Odds of participation in healthy behaviors (tobacco avoidance, avoidance of regular nonsteroidal anti-inflammatory drug use, and physical activity) and achievement of risk-reduction targets (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, systolic blood pressure control and glycemic control among those with diabetes) among those aware versus unaware of their CKD were determined by logistic regression, controlling for sociodemographics, access to care and comorbid conditions. Systolic blood pressure control was defined as <130 mm Hg (primary definition) or <140 mm Hg (secondary definition). RESULTS: Of 2,615 participants, only 6% (n = 166) were aware of having CKD. Those who were aware had 82% higher odds of tobacco avoidance compared to those unaware (adjusted OR = 1.82, 95% CI 1.02-3.24). CKD awareness was not associated with other healthy behaviors or achievement of risk-reduction targets. CONCLUSIONS: Awareness of CKD was only associated with participation in one healthy behavior and was not associated with achievement of risk-reduction targets. To encourage adoption of healthy behaviors, a better understanding of barriers to participation in CKD-healthy behaviors is needed.
BACKGROUND/AIMS: The association between chronic kidney disease (CKD) awareness and healthy behaviors is unknown. We examined whether CKD self-recognition is associated with healthy behaviors and achieving risk-reduction targets known to decrease risk of cardiovascular morbidity and CKD progression. METHODS: CKD awareness, defined as a 'yes' response to 'Has a doctor or other health professional ever told you that you had kidney disease?', was examined among adults with CKD (eGFR <60 ml/min/1.73 m(2)) who participated in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Odds of participation in healthy behaviors (tobacco avoidance, avoidance of regular nonsteroidal anti-inflammatory drug use, and physical activity) and achievement of risk-reduction targets (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use, systolic blood pressure control and glycemic control among those with diabetes) among those aware versus unaware of their CKD were determined by logistic regression, controlling for sociodemographics, access to care and comorbid conditions. Systolic blood pressure control was defined as <130 mm Hg (primary definition) or <140 mm Hg (secondary definition). RESULTS: Of 2,615 participants, only 6% (n = 166) were aware of having CKD. Those who were aware had 82% higher odds of tobacco avoidance compared to those unaware (adjusted OR = 1.82, 95% CI 1.02-3.24). CKD awareness was not associated with other healthy behaviors or achievement of risk-reduction targets. CONCLUSIONS: Awareness of CKD was only associated with participation in one healthy behavior and was not associated with achievement of risk-reduction targets. To encourage adoption of healthy behaviors, a better understanding of barriers to participation in CKD-healthy behaviors is needed.
Authors: Laura C Plantinga; Kirsten Johansen; Deidra C Crews; Vahakn B Shahinian; Bruce M Robinson; Rajiv Saran; Nilka Ríos Burrows; Desmond E Williams; Neil R Powe Journal: Am J Kidney Dis Date: 2010-10-30 Impact factor: 8.860
Authors: Julie A Wright; Kenneth A Wallston; Tom A Elasy; T Alp Ikizler; Kerri L Cavanaugh Journal: Am J Kidney Dis Date: 2010-12-18 Impact factor: 8.860
Authors: Adam Whaley-Connell; James R Sowers; Peter A McCullough; Tricia Roberts; Samy I McFarlane; Shu-Cheng Chen; Suying Li; Changchun Wang; Allan J Collins; George L Bakris Journal: Am J Kidney Dis Date: 2009-04 Impact factor: 8.860
Authors: S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush Journal: Am J Kidney Dis Date: 2009-06-03 Impact factor: 8.860
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Michael J Miller; Michael R Schmitt; Jeroan J Allison; Daniel J Cobaugh; Midge N Ray; Kenneth G Saag Journal: Ann Pharmacother Date: 2010-01-26 Impact factor: 3.154
Authors: Sri Lekha Tummalapalli; Eric Vittinghoff; Deidra C Crews; Mary Cushman; Orlando M Gutiérrez; Suzanne E Judd; Holly J Kramer; Carmen A Peralta; Delphine S Tuot; Michael G Shlipak; Michelle M Estrella Journal: Am J Nephrol Date: 2020-04-29 Impact factor: 3.754
Authors: Janet L Welch; Michelle Johnson; Lani Zimmerman; Cynthia L Russell; Susan M Perkins; Brian S Decker Journal: West J Nurs Res Date: 2014-09-18 Impact factor: 1.967
Authors: Delphine S Tuot; Yunnuo Zhu; Alexandra Velasquez; Juan Espinoza; C Damaris Mendez; Tanushree Banerjee; Chi-Yuan Hsu; Neil R Powe Journal: Clin J Am Soc Nephrol Date: 2016-06-23 Impact factor: 8.237
Authors: Bessie A Young; Ronit Katz; L Ebony Boulware; Bryan Kestenbaum; Ian H de Boer; Wei Wang; Tibor Fülöp; Nisha Bansal; Cassianne Robinson-Cohen; Michael Griswold; Neil R Powe; Jonathan Himmelfarb; Adolfo Correa Journal: Am J Kidney Dis Date: 2016-04-09 Impact factor: 8.860
Authors: Rikki M Tanner; Mark Woodward; Carmen Peralta; David G Warnock; Orlando Gutiérrez; Daichi Shimbo; Holly Kramer; Ronit Katz; Paul Muntner Journal: Ethn Dis Date: 2015-11-05 Impact factor: 1.847
Authors: Chi D Chu; Charles E McCulloch; Tanushree Banerjee; Meda E Pavkov; Nilka R Burrows; Brenda W Gillespie; Rajiv Saran; Michael G Shlipak; Neil R Powe; Delphine S Tuot Journal: Am J Kidney Dis Date: 2020-04-15 Impact factor: 8.860
Authors: Delphine S Tuot; Alexandra Velasquez; Charles E McCulloch; Tanushree Banerjee; Yunnuo Zhu; Chi-yuan Hsu; Margaret Handley; Dean Schillinger; Neil R Powe Journal: BMC Nephrol Date: 2015-10-22 Impact factor: 2.388